ASX - By Stock
|
BUD |
Re:
why I am out
|
|
TTE
|
56 |
33K |
5 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
56
|
33K
|
5
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
3 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
4 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
23K
|
13M
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
9 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
23K
|
13M
|
9
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
TTE
|
29K |
13M |
8 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
29K
|
13M
|
8
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
BUD |
Re:
Charts - BUD
|
|
TTE
|
424 |
189K |
2 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
424
|
189K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
3 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
3
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
06/02/20 |
06/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
2 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
2
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
5 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
5
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
2 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
2
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
0 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
0
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
1 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
1 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
2 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
6 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
23K
|
13M
|
6
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
TTE
|
29K |
13M |
12 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
29K
|
13M
|
12
|
|
ASX - By Stock
|
BRN |
Re:
Akida Documentation
|
|
TTE
|
75 |
58K |
9 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
75
|
58K
|
9
|
|
ASX - By Stock
|
BRN |
Re:
Akida Documentation
|
|
TTE
|
75 |
58K |
4 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
75
|
58K
|
4
|
|
ASX - By Stock
|
CYP |
Re:
2020 - A Year Full Of Potentials
|
|
TTE
|
507 |
1.5M |
3 |
05/02/20 |
05/02/20 |
ASX - By Stock
|
507
|
1.5M
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
TTE
|
23K |
13M |
0 |
04/02/20 |
04/02/20 |
ASX - By Stock
|
23K
|
13M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
1
|
|
ASX - By Stock
|
IXC |
Re:
Why IXC is a Strong BUY awaiting Phase 2 results in March 2020
|
|
TTE
|
46 |
18K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
46
|
18K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
0 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
1 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Submits Completed BLA for Ryoncil to US FDA
|
|
TTE
|
121 |
82K |
3 |
03/02/20 |
03/02/20 |
ASX - By Stock
|
121
|
82K
|
3
|
|